The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
119594636 11959463 6 F 20160102 20160707 20160126 20160715 EXP CA-ROCHE-1698185 ROCHE 58.88 YR M Y 0.00000 20160715 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
119594636 11959463 1 PS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0062,S0065E 103976 300 MG SOLUTION FOR INJECTION
119594636 11959463 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0062,S0065E 103976 SOLUTION FOR INJECTION
119594636 11959463 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0062,S0065E 103976 SOLUTION FOR INJECTION
119594636 11959463 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0062,S0065E 103976 SOLUTION FOR INJECTION
119594636 11959463 5 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0062,S0065E 103976 SOLUTION FOR INJECTION
119594636 11959463 6 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0062,S0065E 103976 SOLUTION FOR INJECTION
119594636 11959463 7 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0062,S0065E 103976 SOLUTION FOR INJECTION
119594636 11959463 8 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0060A,S0062,S0065E 103976 SOLUTION FOR INJECTION
119594636 11959463 9 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0062,S0065E 103976 SOLUTION FOR INJECTION
119594636 11959463 10 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0060A,S0062,S0065E 103976 SOLUTION FOR INJECTION
119594636 11959463 11 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0060A,S0062,S0065E 103976 SOLUTION FOR INJECTION
119594636 11959463 12 C VENTOLIN ALBUTEROL SULFATE 1 Unknown U 0
119594636 11959463 13 C PULMICORT TURBUHALER BUDESONIDE 1 Unknown U 0
119594636 11959463 14 C ADVAIR HFA FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
119594636 11959463 1 Asthma
119594636 11959463 12 Product used for unknown indication
119594636 11959463 13 Product used for unknown indication
119594636 11959463 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
119594636 11959463 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
119594636 11959463 Body temperature decreased
119594636 11959463 Dyspnoea
119594636 11959463 Fall
119594636 11959463 Haemorrhage
119594636 11959463 Increased upper airway secretion
119594636 11959463 Lower respiratory tract infection
119594636 11959463 Nasopharyngitis
119594636 11959463 Skeletal injury
119594636 11959463 Upper respiratory tract infection
119594636 11959463 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
119594636 11959463 1 20120905 0
119594636 11959463 2 20130705 0
119594636 11959463 3 20131010 0
119594636 11959463 4 20140206 0
119594636 11959463 5 20160115 0
119594636 11959463 6 20160212 0
119594636 11959463 7 20160315 0
119594636 11959463 8 20160415 0
119594636 11959463 9 20160513 0
119594636 11959463 10 20160610 0
119594636 11959463 11 20160707 0